Sitagliptin is a DPP-4 inhibitor that helps regulate insulin levels after meals in patients with diabetes.
Sitagliptin belongs to a class of medicines known as DPP-4 inhibitors. It helps the body regulate blood-sugar levels by enhancing the natural hormones that control insulin release after meals. In Hong Kong, sitagliptin is found in several prescription products, the most common being the tablet-form brand Istamet.
The principal medication that contains sitagliptin in the Hong Kong market is Istamet. It is supplied as oral tablets in strengths of 50 mg and 100 mg. Both strengths are available as generic versions and as the branded product. While Istamet is the only name listed here, other manufacturers may market the same ingredient under different generic names; all of these follow the same regulatory standards set by the Hong Kong Department of Health.
Sitagliptin is used when a person’s blood-sugar control needs additional support beyond diet, exercise and other oral antidiabetic agents. The principal conditions include:
The drug is intended for adult patients who have been diagnosed with type 2 diabetes. Its use is based on the approval by the Hong Kong regulatory authorities, and any off-label applications should be discussed with a qualified healthcare professional.
When food is eaten, the gut releases hormones called incretins that tell the pancreas to release insulin. An enzyme called DPP-4 quickly breaks down these hormones. Sitagliptin blocks DPP-4, allowing the incretin hormones to stay active longer. This results in a modest increase in insulin after meals and a reduction in the amount of glucose released by the liver, helping to keep blood-sugar levels within a healthier range. The effect begins within a few days of regular use and is maintained as long as the medication is taken.
Most people experience few problems. Frequently reported, mild reactions include:
These effects are usually temporary and resolve without medical intervention.
Rare but important signs that require urgent attention are:
If any of these occur, seek immediate medical help.
Certain groups need extra care when using sitagliptin:
Sitagliptin can interact with other substances:
For a full list of interactions, refer to the individual product information for Istamet or speak with a pharmacist.
This article offers general educational information about sitagliptin as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing sitagliptin may differ in formulation, strength, and directions for use. Always consult the labelling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.